Find Support on Your Journey
Latest News
July 24, 2025
FDA Extends Review of Blenrep Combinations in Multiple Myeloma – Managed Healthcare Executive
July 24, 2025
Complement Inhibitor Gefurulimab Meets End Points in Phase 3 PREVAIL Study of Myasthenia Gravis
AstraZeneca’s gefurulimab shows promising results in treating generalized myasthenia gravis, offering patients a convenient, self-administered therapy option.
Looking for a Clinical Trial?
As of July 12, 2025
3077 Breast Cancer Clinical Trials are now recruiting
2975 Lung Cancer Clinical Trials are now recruiting
2029 Colorectal Cancer Clinical Trials are now recruiting
1386 Prostate Cancer Clinical Trials are now recruiting
1156 Pancreatic Cancer Clinical Trials are now recruiting
Source: clinicaltrials.gov